Cite
HARVARD Citation
Briand, F. et al. (2020). A 3‐week nonalcoholic steatohepatitis mouse model shows elafibranor benefits on hepatic inflammation and cell death. Clinical and translational science. 13 (3), pp. 529-538. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Briand, F. et al. (2020). A 3‐week nonalcoholic steatohepatitis mouse model shows elafibranor benefits on hepatic inflammation and cell death. Clinical and translational science. 13 (3), pp. 529-538. [Online].